{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADXS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADXS\",,,,,undefined,":{"symbol":"ADXS","market":"US","secType":"STK","nameCN":"Ayala Pharmaceuticals, Inc.","latestPrice":0.60355,"timestamp":1770411600000,"preClose":0.60355,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":18100900,"shares":42593900,"eps":-7.986625,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 16:00:00 EST Delay","open":0.60355,"high":0.60355,"low":0.60355,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-7.986625,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"EXPERT","adjPreClose":0.60355,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADXS\",,,,,undefined,":{"symbol":"ADXS","floatShares":18100900,"roa":"-181.05%","roe":"-392.03%","lyrEps":-7.986625,"shares":42593900,"dividePrice":0,"high":0.60355,"amplitude":0,"preClose":0.60355,"low":0.60355,"week52Low":0.0011,"pbRate":"-1.05","psRate":"1977.50","week52High":0.801,"institutionHeld":0,"latestPrice":0.60355,"eps":-7.986625,"divideRate":0,"volume":0,"delay":15,"ttmEps":-7.986625,"open":0.60355,"prevYearClose":0.0401,"prevWeekClose":0.57,"prevMonthClose":0.57,"prevQuarterClose":0.0401},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADXS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-04","symbol":"ADXS","reason":null,"defaultRemindTime":1770215400000,"announcedDate":"2026-02-03","type":"delisting","dateTimestamp":1770181200000},{"market":"US","date":"2022-09-12","symbol":"ADXS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1662955200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-06-06","symbol":"ADXS","defaultRemindTime":1654522200000,"type":"split","dateTimestamp":1654488000000,"forFactor":80,"toFactor":1,"ratio":80},{"market":"US","date":"2021-09-10","symbol":"ADXS","fiscalQuarterEnding":"2021/07","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1631246400000,"reportTimeType":"pre","actualEps":-0.02},{"market":"US","date":"2021-06-14","symbol":"ADXS","fiscalQuarterEnding":"2021/04","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1623643200000,"reportTimeType":"","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADXS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADXS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADXS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADXS","date":"2021-12-21","current":-2.2851,"percent":0.38764,"low":-10.115853,"twenty":-3.753596,"median":-1.301833,"eighty":-0.326835,"high":-0.062533,"avg":-2.182396,"sd":2.116831,"marketCap":43138111},"quantilePoints":[{"date":"2021-02-12","current":-4.674476,"twenty":-8.43427,"median":-1.302224,"eighty":-0.327449,"marketCap":123728715},{"date":"2021-02-19","current":-5.076354,"twenty":-8.342184,"median":-1.302224,"eighty":-0.327449,"marketCap":134366025},{"date":"2021-02-26","current":-3.735351,"twenty":-8.130804,"median":-1.302224,"eighty":-0.327449,"marketCap":98871000},{"date":"2021-03-05","current":-2.983627,"twenty":-7.523871,"median":-1.302029,"eighty":-0.327142,"marketCap":78973631},{"date":"2021-03-12","current":-3.473919,"twenty":-5.928978,"median":-1.302029,"eighty":-0.327142,"marketCap":91951150},{"date":"2021-03-19","current":-4.431937,"twenty":-5.796985,"median":-1.301833,"eighty":-0.326835,"marketCap":100113027},{"date":"2021-03-26","current":-3.977108,"twenty":-5.710324,"median":-1.302029,"eighty":-0.327142,"marketCap":89838898},{"date":"2021-04-01","current":-3.893547,"twenty":-5.670327,"median":-1.302029,"eighty":-0.327142,"marketCap":87951325},{"date":"2021-04-09","current":-3.754464,"twenty":-5.550334,"median":-1.301833,"eighty":-0.326835,"marketCap":84809589},{"date":"2021-04-16","current":-2.766952,"twenty":-5.506336,"median":-1.301833,"eighty":-0.326835,"marketCap":62502681},{"date":"2021-04-23","current":-2.919356,"twenty":-5.457006,"median":-1.301833,"eighty":-0.326835,"marketCap":65945342},{"date":"2021-04-30","current":-3.009136,"twenty":-5.399676,"median":-1.302029,"eighty":-0.327142,"marketCap":67973368},{"date":"2021-05-07","current":-2.55291,"twenty":-5.377011,"median":-1.302029,"eighty":-0.327142,"marketCap":57667684},{"date":"2021-05-14","current":-2.271968,"twenty":-5.330347,"median":-1.302029,"eighty":-0.327142,"marketCap":51321479},{"date":"2021-05-21","current":-3.346877,"twenty":-5.301015,"median":-1.302224,"eighty":-0.327449,"marketCap":75602609},{"date":"2021-05-28","current":-3.001807,"twenty":-5.239686,"median":-1.302224,"eighty":-0.327449,"marketCap":67807815},{"date":"2021-06-04","current":-3.175869,"twenty":-5.194355,"median":-1.302224,"eighty":-0.327449,"marketCap":71739702},{"date":"2021-06-11","current":-3.202742,"twenty":-5.101067,"median":-1.302224,"eighty":-0.327449,"marketCap":72346731},{"date":"2021-06-18","current":-3.338925,"twenty":-4.858321,"median":-1.302224,"eighty":-0.327449,"marketCap":71362844},{"date":"2021-06-25","current":-3.372996,"twenty":-4.685103,"median":-1.302224,"eighty":-0.327449,"marketCap":72091037},{"date":"2021-07-02","current":-3.255111,"twenty":-4.566651,"median":-1.302224,"eighty":-0.327449,"marketCap":69571491},{"date":"2021-07-09","current":-3.366863,"twenty":-4.498845,"median":-1.302224,"eighty":-0.327449,"marketCap":71959962},{"date":"2021-07-16","current":-3.060908,"twenty":-4.466254,"median":-1.302224,"eighty":-0.327449,"marketCap":65420795},{"date":"2021-07-23","current":-2.957334,"twenty":-4.429881,"median":-1.302224,"eighty":-0.327449,"marketCap":63207091},{"date":"2021-07-30","current":-2.807423,"twenty":-4.397371,"median":-1.302224,"eighty":-0.327449,"marketCap":60003045},{"date":"2021-08-06","current":-2.971643,"twenty":-4.319203,"median":-1.302224,"eighty":-0.327449,"marketCap":63512931},{"date":"2021-08-13","current":-2.927351,"twenty":-4.272365,"median":-1.302224,"eighty":-0.327449,"marketCap":62566281},{"date":"2021-08-20","current":-2.634344,"twenty":-4.24616,"median":-1.302224,"eighty":-0.327449,"marketCap":56303828},{"date":"2021-08-27","current":-3.194465,"twenty":-4.207084,"median":-1.301833,"eighty":-0.326835,"marketCap":68275309},{"date":"2021-09-03","current":-3.159032,"twenty":-4.144564,"median":-1.301833,"eighty":-0.326835,"marketCap":67517989},{"date":"2021-09-10","current":-3.190377,"twenty":-4.12073,"median":-1.301833,"eighty":-0.326835,"marketCap":68187926},{"date":"2021-09-17","current":-4.037112,"twenty":-4.102884,"median":-1.301833,"eighty":-0.326835,"marketCap":76212605},{"date":"2021-09-24","current":-4.087258,"twenty":-4.062507,"median":-1.301833,"eighty":-0.326835,"marketCap":77159255},{"date":"2021-10-01","current":-4.023226,"twenty":-4.026063,"median":-1.301833,"eighty":-0.326835,"marketCap":75950456},{"date":"2021-10-08","current":-3.625918,"twenty":-3.978738,"median":-1.301833,"eighty":-0.326835,"marketCap":68450075},{"date":"2021-10-15","current":-3.749353,"twenty":-3.966062,"median":-1.301833,"eighty":-0.326835,"marketCap":70780291},{"date":"2021-10-22","current":-3.885132,"twenty":-3.950462,"median":-1.301833,"eighty":-0.326835,"marketCap":73343527},{"date":"2021-10-29","current":-3.735467,"twenty":-3.933481,"median":-1.301833,"eighty":-0.326835,"marketCap":70518141},{"date":"2021-11-05","current":-3.854273,"twenty":-3.918915,"median":-1.301833,"eighty":-0.326835,"marketCap":72760974},{"date":"2021-11-12","current":-3.425335,"twenty":-3.905807,"median":-1.301833,"eighty":-0.326835,"marketCap":64663475},{"date":"2021-11-19","current":-2.909992,"twenty":-3.888494,"median":-1.301833,"eighty":-0.326835,"marketCap":54934826},{"date":"2021-11-26","current":-2.967852,"twenty":-3.868828,"median":-1.301833,"eighty":-0.326835,"marketCap":56027115},{"date":"2021-12-03","current":-2.655406,"twenty":-3.846404,"median":-1.301833,"eighty":-0.326835,"marketCap":50128757},{"date":"2021-12-10","current":-2.683179,"twenty":-3.806425,"median":-1.301833,"eighty":-0.326835,"marketCap":50653056},{"date":"2021-12-17","current":-2.391563,"twenty":-3.767552,"median":-1.301833,"eighty":-0.326835,"marketCap":45147922},{"date":"2021-12-21","current":-2.2851,"twenty":-3.753596,"median":-1.301833,"eighty":-0.326835,"marketCap":43138111}],"updateTime":1770437483311},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADXS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590535898","title":"OS Therapies Unveils Cancer Immunotherapy Pipeline and Market Strategy in New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2590535898","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590535898?lang=en_us&edition=fundamental","pubTime":"2025-12-10 22:57","pubTimestamp":1765378623,"startTime":"0","endTime":"0","summary":"OS Therapies Inc. has published a corporate presentation highlighting its clinical-stage pipeline and financial summary. The company reports over $300 million invested in its listeria immunotherapy platform, acquired from Advaxis/Ayala in April 2025. The lead program, OST-HER2, targets osteosarcoma and has potential follow-on applications in breast cancer and other solid tumors. The total addressable market for these assets is estimated at $258 billion. The company is targeting accelerated approval for OST-HER2 in human osteosarcoma between April and September 2026, with a projected Priority Review Voucher sale of approximately $160 million. The clinical pipeline also includes candidates for HPV cancers, non-small cell lung cancer, glioblastoma, breast cancer, and prostate cancer. Current financials show a market cap of $60 million, cash holdings of approximately $4 million, and a monthly cash burn of about $300,000. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDLWhznZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADXS","OSTX","BK4139"],"gpt_icon":0},{"id":"2577680447","title":"OS Therapies Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2577680447","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577680447?lang=en_us&edition=fundamental","pubTime":"2025-10-22 04:16","pubTimestamp":1761077818,"startTime":"0","endTime":"0","summary":"OS Therapies Inc. held its annual meeting of stockholders on October 21, 2025. Stockholders elected Paul A. Romness, John Ciccio, Avril McKean Dieser, Karim Galzahr, Olivier R. Jarry, and Theodore F. Search to the board of directors. Approval was granted for the issuance of shares of common stock to Ayala Pharmaceuticals, Inc. in connection with an asset purchase transaction. Stockholders also approved an amendment to increase the number of authorized shares of common stock from 50 million to 150 million. An amendment to the company's incentive compensation plan was approved, increasing the number of shares available for issuance under the plan and the maximum number of shares that may be granted to an individual as performance-based compensation. A resolution approving a shareholder rights agreement and authorizing the board of directors to implement it when deemed appropriate was adopted. Additionally, the appointment of MaloneBailey, LLP as independent registered public accounting f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL3vp3V2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADXS","BK4139","OSTX"],"gpt_icon":0},{"id":"2576063323","title":"OS Therapies Inc. Unveils Cancer Immunotherapy Advances and Pipeline Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2576063323","media":"Reuters","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576063323?lang=en_us&edition=fundamental","pubTime":"2025-10-18 02:14","pubTimestamp":1760724872,"startTime":"0","endTime":"0","summary":"OS Therapies Inc. has released a corporate presentation highlighting its recent developments and pipeline progress. The company has acquired all listeria-based assets from Advaxis/Ayala, with over $300 million invested in the listeria platform to date. Its lead clinical program, OST-HER2, targets osteosarcoma with additional applications in breast cancer and other solid tumors. The total addressable market for these assets and follow-on applications is estimated at $258 billion. OST-HER2 has received orphan drug, fast track, and rare pediatric disease designations from the FDA, and the company is preparing for meetings with global regulatory agencies regarding submissions for human osteosarcoma. Accelerated approval is targeted for 2026, and a Priority Review Voucher could be issued upon approval, with recent comparable sales valued at $160 million. Other pipeline highlights include a next-generation tunable drug conjugate  and ongoing clinical and preclinical programs in multiple canc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDLb9DPvd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","ADXS","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ADXS\",params:#limit:6,delay:false,,,undefined,":[]}}